Journal Article

Health-related quality of life in early-stage Hodgkin lymphoma: a longitudinal analysis of the ABVD arm in the randomized controlled trial HD.6

Prica, Anca, Winter, Jane N., Meyer, Ralph, Chen, Bingshu E., Ringash, Jolie, Djurfeldt, Marina, Pater, Joseph, Sussman, Jonathan, Shepherd, Lois, Mian, Hira, Hay, Annette E.

2023

Overview

Early-stage Hodgkin lymphoma has become one of the most curable hematologic malignancies. Depending upon the disease location, possible toxicities, and patient preference, chemotherapy alone with ABVD remains an accepted treatment modality for this disease. There remains a paucity of data regarding the longitudinal trajectory of health-related quality of life (HRQoL) in patients treated for HL. The impact of disease and treatment on HRQoL is increasingly important to understand as the number of long-term survivors increases. We report the longitudinal HRQoL using data prospectively collected from diagnosis up to 10 years post-treatment in the ABVD arm of the HD.6 randomized controlled trial for early-stage HL patients ( N =169). We analyzed HRQoL using the EORTC QLQ-C30 collected at baseline, 3 months, 6 months, and 12 months after completion of chemotherapy and yearly up to year 10. Clinically and statistically significant improvements were noted for specific domains including emotional (3 months post-treatment), social (12 months post-treatment) and financial functioning (2 years post-treatment), and the specific symptom of fatigue (6 months post-treatment) during the follow-up period. To our knowledge, this is the first prospective, longitudinal analysis of HRQoL specifically among patients with early-stage HL treated with ABVD therapy alone. Although improvements were noted, sustained clinically and statistically significant improvements were noted only in select symptoms emphasizing the need to better understand and optimize HRQoL among this patient group.

• Publisher: Springer Berlin Heidelberg,Springer,Springer Nature B.V
• Subject: Analysis / Antineoplastic Combined Chemotherapy Protocols - adverse effects / Bleomycin / Blood cancer / Cancer / Care and treatment / Chemotherapy / Clinical trials / Dacarbazine - therapeutic use / Data quality / Disease / Doxorubicin - adverse effects / Health status / Hodgkin Disease - pathology / Hodgkin's lymphoma / Humans / Long term survivor / Lymphoma / Lymphomas / Medical diagnosis / Medical treatment / Medicine / Medicine & Public Health / Nursing / Nursing Research / Oncology / Pain Medicine / Patients / Prospective Studies / Quality of Life / Rehabilitation Medicine / Symptoms / Vinblastine - therapeutic use